<DOC>
	<DOCNO>NCT01579565</DOCNO>
	<brief_summary>The purpose study determine safety , efficacy pharmacokinetics OMS302 ( study drug ) maintain intraoperative mydriasis prevent post operative pain individual undergo Intraocular Lens Replacement ( ILR ) surgery .</brief_summary>
	<brief_title>Safety , Efficacy Pharmacokinetics OMS302 Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Competent willing voluntarily provide informed consent 18 year age older In good general health need undergo cataract extraction lens extraction lens replacement surgery one eye , topical anesthesia No allergy medication and/or active ingredient study medication No medication activity active ingredient OMS302 define time interval prior surgery No significant eye injury , eye condition general medical condition likely interfere evaluation study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cataract</keyword>
	<keyword>lens replacement</keyword>
</DOC>